Orthostatic intolerance (OI) is defined as the development of characteristic symptoms while standing, which significantly improve by recumbency. The most common forms are vasovagal syncope (VVS), orthostatic hypotension, and postural orthostatic tachycardia syndrome (POTS). Lately, there has been a growing body of evidence that autoimmunity may play a role in the pathophysiology of orthostatic intolerance syndromes. The aim was to compare the presence and levels of autoimmune autoantibodies in patients with POTS, VVS syncope, and the control group. Altogether, 61 patients with symptoms of orthostatic intolerance were evaluated in this study - 19 POTS patients and 42 VVS patients. The control group contained 22 patients with no signs of orthostatic intolerance. We evaluated levels of autoantibodies against three subtypes of G-protein coupled adrenergic receptor (alpha-1 and beta-1,2 adrenergic receptors), type 4 of muscarinic acetylcholine receptor, and angiotensin II type 1 receptor. We compared the levels between the three patient groups. Significantly higher levels of angiotensin II type 1 receptor (AT1R) autoantibodies were found in the POTS group compared with controls (0.67± 0.35 ng/ml vs. 0.38±0.32 ng/ml, p=0.008). There was no significant difference in AT1R antibodies between the VVS and control groups (0.46±0.34 ng/ml vs 0.38±0.32 ng/ml, p= 0.38). Autoantibody concentration against ADRA1, ADRB1, ADRB2, and M4R were not significantly different between the groups. Autoimmune mechanisms may lead to abnormal regulation of the renin-angiotensin-aldosterone system and may contribute to the pathophysiology of POTS.

1st Department of Cardiology VUSCH P J Safarik University Kosice Slovakia

Zobrazit více v PubMed

Okamoto LE, Raj SR, Biaggioni I. Primer on the Autonomic Nervous System. In: Robertson D, editor. Chronic Fatigue Syndrome and the Autonomic Nervous System. 3rd edn. Academic Press, United States of America; 2012. pp. 531–534. DOI

Sheldon RS, Grubb BP, Olshansky B, Shen W-K, Calkins H, Brignole M, Raj SR, et al. 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope. Heart Rhythm. 2015;12:e41–e63. doi: 10.1016/j.hrthm.2015.03.029. PubMed DOI PMC

Kenny RA, McNicholas T. The management of vasovagal syncope. QJM. 2016;109:767–773. doi: 10.1093/qjmed/hcw089. PubMed DOI

Aboseif A, Bireley JD, Yuebing L, Polston D, Abbatemarco JR. Autoimmunity and postural orthostatic tachycardia syndrome: Implications in diagnosis and management. Cleve Clin J Med. 2023;90:439–447. doi: 10.3949/ccjm.90a.22093. PubMed DOI

Olshansky B, Cannom D, Fedorowski A, Stewart J, Gibbons C, Sutton R, Shen W-K, et al. Postural orthostatic tachycardia syndrome (POTS): A critical assessment. Prog Cardiovasc Dis. 2020;63:263–270. doi: 10.1016/j.pcad.2020.03.010. PubMed DOI PMC

Raj SR, Fedorowski A, Sheldon RS. Diagnosis and management of postural orthostatic tachycardia syndrome. CMAJ. 2022;14:194. doi: 10.1503/cmaj.211373. PubMed DOI PMC

Yu X, Li H, Murphy TA, Nuss Z, Liles J, Liles C, Aston CE, et al. Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome. J Am Heart Assoc. 2018;7:8. doi: 10.1161/JAHA.117.008351. PubMed DOI PMC

Fedorowski A, Li H, Yu X, Koelsch KA, Harris VM, Liles C, Murphy TA, et al. Antiadrenergic autoimmunity in postural tachycardia syndrome. Europace. 2017;19:1211–1219. doi: 10.1093/europace/euw154. PubMed DOI PMC

Wang XL, Chai Q, Charlesworth MC, Figueroa JJ, Shen W-K, Lee HC. Autoimmunoreactive IgGs from patients with postural orthostatic tachycardia syndrome. Proteomics Clin Appl. 2012;6:615–625. doi: 10.1002/prca.201200049. PubMed DOI PMC

Li H, Yu X, Liles C, Khan M, Vanderlinde-Wood M, Galloway A, et al. Autoimmune Basis for Postural Tachycardia Syndrome. J Am Heart Assoc. 2014:3. doi: 10.1161/JAHA.113.000755. PubMed DOI PMC

Goodman BP. Evaluation of postural tachycardia syndrome (POTS) Auton Neurosci. 2018;215:12–19. doi: 10.1016/j.autneu.2018.04.004. PubMed DOI

Lu CC, Tseng CJ, Tang HS, Tung CS. Orthostatic intolerance: Potential Pathophysiology and Therapy. Chin J Physiol. 2004;47:101–109. PubMed

Gunning WT, Kvale H, Kramer PM, Karabin BL, Grubb BP. Postural Orthostatic Tachycardia Syndrome Is Associated With Elevated G-Protein Coupled Receptor Autoantibodies. J Am Heart Assoc. 2019;8:18. doi: 10.1161/JAHA.119.013602. PubMed DOI PMC

Li H, Zuccolo J, Kem DC, Zillnes C, Lee J, Smith K, James JA, et al. Implications of a Vasodilatory Human Monoclonal Autoantibody in Postural Hypotension. J Biol Chem. 2013;288:30734–30741. doi: 10.1074/jbc.M113.477869. PubMed DOI PMC

Brignole M, Moya A, de Lange FJ, Deharo JC, Elliot PM, Faniciulli A, Fedorowski A, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39:1883–1948. doi: 10.5603/KP.2018.0161. PubMed DOI

Mustafa HI, Garland EM, Biaggioni I, Black BK, Dupont WD, Robertson D, Raj SR. Abnormalities of angiotensin regulation in postural tachycardia syndrome. Heart Rhythm. 2011;8:422–428. doi: 10.1016/j.hrthm.2010.11.009. PubMed DOI PMC

Mustafa HI, Raj SR, Diedrich A, black BK, Paranjape SY, Dupont WD, et al. Altered Systemic Hemodynamic & Baroreflex Response to Angiotensin II in Postural Tachycardia Syndrome. Circ Arrhythm Electrophysiol. 2012;5:173–180. doi: 10.1161/CIRCEP.111.965343. PubMed DOI PMC

Spahic JM, Matisson IY, Hamrefors V, Johansson M, Ricci F, Nilsson J, Melander O, et al. Evidence for Impaired Renin Activity in Postural Orthostatic Tachycardia Syndrome. J Clin Med. 2023;12:4660. doi: 10.3390/jcm12144660. PubMed DOI PMC

Dubey J, Hopkins S, Vernino S. M1 and M2 muscarinic receptor antibodies among patients with postural orthostatic tachycardia syndrome: potential disease biomarker. J Clin Neuromuscul Dis. 2016;17:179.

Hall J, Bourne KM, Vernino S, Hamrefors V, Kharraziha I, Nilsson J, Sheldon RS, et al. Detection of G Protein-Coupled Receptor Autoantibodies in Postural Orthostatic Tachycardia Syndrome Using Standard Methodology. Circulation. 2022;146:613–622. doi: 10.1161/CIRCULATIONAHA.122.059971. PubMed DOI PMC

Li H, Zhang G, Zhou L, Nuss Z, Beel M, Hines B, Murphy T, et al. Adrenergic Autoantibody-Induced Postural Tachycardia Syndrome in Rabbits. J Am Heart Assoc. 2019;8:19. doi: 10.1161/JAHA.119.013006. PubMed DOI PMC

Vernino S, Stiles L. Autoimmunity in Postural Orthostatic Tachycardia Syndrome: Current Understanding. Auton Neurosci. 2018;215:78–82. doi: 10.1016/j.autneu.2018.04.005. PubMed DOI